Tag: Quality Systems

Addressing Poor Justification of Design Space During the Pilot Scale: A Structured CAPA Approach The pharmaceutical industry often faces challenges related to design space justifications during the pilot scale of…

“`html Enhancing Data Packages for Design Space Justification During Scale-Up In the pharmaceutical manufacturing landscape, a poorly justified design space during scale-up can spell trouble for compliance and market readiness.…

Understanding the Risk of Uncaptured Process Knowledge in Manufacturing Transfers In the pharmaceutical industry, the transfer of process knowledge from research and development (R&D) to manufacturing is crucial for ensuring…

“`html Risk Management Strategies for Poorly Justified Design Space during Pilot Scale Operations In the pharmaceutical manufacturing landscape, pilot scale operations play a crucial role in bridging the gap between…

“`html Understanding the Impact of Excipient Variability During Manufacturing Transfers Variability in excipients can significantly affect the quality and consistency of pharmaceutical products, particularly during the transfer from development to…

Addressing Tech Transfer Readiness Gaps during Comparability Assessment: A Structured Investigative Approach Tech transfer readiness gaps can significantly impede the comparability assessment process, leading to deviations that are costly and…

Understanding the Implications of Excipient Variability During Early Development In pharmaceutical manufacturing, excipients play a critical role in ensuring the efficacy and stability of drug formulations. However, variability in excipients…

Addressing Underestimated Formulation Robustness during Scale-Up: Key Steps for Effective Tech Transfer In the pharmaceutical industry, the inadequacy of formulation robustness can significantly impact product quality during scale-up processes. Such…

Addressing Method Development Instability During Pilot Scale: Implications for Regulatory Scrutiny In the context of pharmaceutical development, method instability during pilot scale processes often results in significant challenges. These challenges…

Addressing Method Development Instability During the Early Development Lifecycle In the pharmaceutical landscape, method development instability can pose significant challenges, particularly during the early phases of product development. Instabilities can…

Improving Data Package for Regulatory Filing When Process Knowledge is Lacking During Pilot Scale In pharmaceutical development, capturing process knowledge during pilot scale manufacturing is critical for ensuring product quality…

Addressing Readiness Gaps for a Seamless Transfer to Manufacturing When transitioning from research and development to manufacturing, organizations often encounter significant readiness gaps that may jeopardize compliance with Good Manufacturing…